NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹126 Cr | ₹115 Cr | ₹126 Cr | ₹104 Cr | ₹108 Cr |
What is the latest Net Current Assets ratio of NGL FINECHEM ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹126 Cr |
| Mar2025 | ₹115 Cr |
| Mar2024 | ₹126 Cr |
| Mar2023 | ₹104 Cr |
| Mar2022 | ₹108 Cr |
How is Net Current Assets of NGL FINECHEM Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹126 Cr | 9.46 | |
| Mar2025 | ₹115 Cr | -8.42 | |
| Mar2024 | ₹126 Cr | 20.81 | |
| Mar2023 | ₹104 Cr | -3.22 | |
| Mar2022 | ₹108 Cr | - | |
Compare Net Current Assets of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,769.8 Cr | -8.4% | 3.4% | 97.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -8.4% |
3.4% |
97.3% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses